Skip to NavigationSkip to content

News

0
First-ever study in the personalised treatment of rare cancers brings promising results
The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual disease has...
0
Breakthrough AI able to identify 97% of breast cancer risk
Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose...
0
Novartis sheds generics plant and 450 jobs amid pricing pressure
Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will lead to a loss of...
0
New studies point to cracks forming in NHS services
Two studies published separately by the BBC and the Care Quality Commission point to growing problems across NHS services in the UK, with increased...
>> More News Stories

Features

Allergan’s patent shield – The (Native) American dream?

In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering its...

>> More Features
>> More News Stories